)
)
The Role of Liquid Biopsy in The NHS Cancer Diagnostic Pathways
-
The QuicDNA real-world evaluation project has significantly advanced our understanding of introducing circulating tumour DNA (ctDNA) testing at an early stage in the lung cancer diagnostic pathway.
-
Leveraging this foundational experience, the established infrastructure, and ongoing clinical momentum, NHS Wales is now positioned to extend the use of innovative liquid biopsy testing to additional tumour sites.
